Feb 15, 2017ACQUISITIONUnited States Integra LifeSciences to acquire Codman Neurosurgery from Johnson & Johnson for $1.045 billion
Integra LifeSciences has made a binding offer to acquire the Codman Neurosurgery business from Johnson & Johnson for $1.045 billion in cash. The acquisition includes a portfolio of devices for hydrocephalus, neuro-critical care, and operative neurosurgery.
Productsneurosurgical deviceshydrocephalus devicesneuro-critical care deviceselectrosurgery devices
“This proposed transformational acquisition of Codman Neurosurgery creates compelling value for our shareholders, employees and patients.”investor.integralife.com
- 2 sources
- investor.integralife.comIntegra LifeSciences Plans to Acquire the Codman Neurosurgery Business from Johnson & Johnson for $1.045 Billion in Cash | Integra LifeSciences Holdings CorporationFeb 15, 2017
- neuronewsinternational.comIntegra LifeSciences to acquire Codman Neurosurgery business from Johnson & Johnson - NeuroNews InternationalMar 8, 2017
Summarized from public sources; check the original articles before acting on it.
ENDATA